Prematür Ejakülasyon

Waldinger, M.D. and D.H. Schweitzer, Changing paradigms from a historical DSM‐III and DSM‐IV view toward an evidence‐based definition of premature ejaculation. Part II—Proposals for DSM‐V and ICD‐11. The journal of sexual medicine, 2006. 3(4): p. 693-705.

Waldinger, M.D. and D.H. Schweitzer, Differences between ICD-11 MMS and DSM-5 definition of premature ejaculation: a continuation of historical inadequacies and a source of serious misinterpretation by some European Regulatory Agencies (PART 2). International Journal of Impotence Research, 2019. 31(5): p. 310-318.

Saitz, T.R. and E.C. Serefoglu, The epidemiology of premature ejaculation. Translational andrology and urology, 2016. 5(4): p. 409.

Gao, J., et al., The Impact of Intravaginal Ejaculatory Latency Time and Erectile Function on Anxiety and Depression in the Four Types of Premature Ejaculation: A Large Cross‐Sectional Study in a C hinese Population. The Journal of Sexual Medicine, 2014. 11(2): p. 521-528.

Wiggins, A., et al., The penile sensitivity ratio: a novel application of biothesiometry to assess changes in penile sensitivity. The Journal of Sexual Medicine, 2019. 16(3): p. 447-451.

Khan, H., et al., Serotonin transporter (5‐HTTLPR) genotypes and trinucleotide repeats of androgen receptor exert a combinatorial effect on hormonal milieu in patients with lifelong premature ejaculation. Andrology, 2018. 6(6): p. 916-926.

Waldinger, M.D., Pathophysiology of lifelong premature ejaculation. Premature Ejaculation, 2013: p. 71-80.

Carani, C., et al., Multicenter study on the prevalence of sexual symptoms in male hypo-and hyperthyroid patients. The Journal of Clinical Endocrinology & Metabolism, 2005. 90(12): p. 6472-6479.

Corona, G., et al., Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. European urology, 2004. 46(5): p. 615-622.

McMahon, C.G., et al., The pathophysiology of acquired premature ejaculation. Translational Andrology and Urology, 2016. 5(4): p. 434.

Verze, P., et al., Premature ejaculation among Italian men: prevalence and clinical correlates from an observational, non-interventional, cross-sectional, epidemiological study (IPER). Sexual medicine, 2018. 6(3): p. 193-202.

Laumann, E.O., et al., Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. International journal of impotence research, 2005. 17(1): p. 39-57.

Janssen, P.K., et al., Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. The journal of sexual medicine, 2009. 6(1): p. 276-284.

Laumann, E.O., A. Paik, and R.C. Rosen, Sexual dysfunction in the United States: prevalence and predictors. Jama, 1999. 281(6): p. 537-544.

Kim, M., et al., Erectile dysfunction in patients with liver disease related to chronic hepatitis B. Clinical and molecular hepatology, 2015. 21(4): p. 352.

Corona, G., et al., ORIGINAL RESEARCH–ENDOCRINOLOGY: Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual Dysfunction. The journal of sexual medicine, 2009. 6(5): p. 1457-1466.

Corona, G., et al., Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. International journal of andrology, 2011. 34(1): p. 41-48.

Kadihasanoglu, M., et al., Relation between blood vitamin B12 levels with premature ejaculation: case–control study. Andrologia, 2017. 49(5): p. e12657.

GamalEl Din, S.F., et al., Serum vitamin D level may be a novel potential risk factor for premature ejaculation: a comparative study. International Urology and Nephrology, 2018. 50(11): p. 1975-1980.

Bolat, D., et al., The relationship between acquired premature ejaculation and metabolic syndrome: a prospective, comparative study. International journal of impotence research, 2017. 29(3): p. 105-109.

Dunn, K.M., P.R. Croft, and G.I. Hackett, Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. Journal of Epidemiology & Community Health, 1999. 53(3): p. 144-148.

Xia, Y., et al., Relationship between premature ejaculation and depression: A PRISMA-compliant systematic review and meta-analysis. Medicine, 2016. 95(35).

Corona, G., et al., Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta‐analysis. The Journal of Sexual Medicine, 2015. 12(12): p. 2291-2300.

Althof, S.E., et al., International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. The journal of sexual medicine, 2010. 7(9): p. 2947-2969.

Waldinger, M.D., et al., Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. The Journal of Sexual Medicine, 2008. 5(2): p. 492-499.

Arafa, M. and R. Shamloul, Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). The journal of sexual medicine, 2007. 4(6): p. 1750-1756.

Shabsigh, R., Diagnosing premature ejaculation: a review. The journal of sexual medicine, 2006. 3: p. 318-323.

Althof, S.E., et al., An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). The journal of sexual medicine, 2014. 11(6): p. 1392-1422.

Althof, S.E., Psychosexual therapy for premature ejaculation. Translational Andrology and Urology, 2016. 5(4): p. 475.

Pavone, C., et al., Premature ejaculation: Pharmacotherapy vs group psychotherapy alone or in combination. Archivio Italiano di Urologia e Andrologia, 2017. 89(2): p. 114-119.

Melnik, T., et al., Psychosocial interventions for premature ejaculation. Sao Paulo Medical Journal, 2012. 130: p. 132-132.

Kempeneers, P., et al., Sexual cognitions, trait anxiety, sexual anxiety, and distress in men with different subtypes of premature ejaculation and in their partners. Journal of Sex & Marital Therapy, 2018. 44(4): p. 319-332.

Cormio, L., et al., The combination of dapoxetine and behavioral treatment provides better results than dapoxetine alone in the management of patients with lifelong premature ejaculation. The journal of sexual medicine, 2015. 12(7): p. 1609-1615.

McMahon, C.G., et al., Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. The journal of sexual medicine, 2011. 8(2): p. 524-539.

McMahon, C., et al., The Asia-Pacific flexible dose study of dapoxetine and patient satisfaction in premature ejaculation therapy: the PASSION study. Sexual Medicine, 2016. 4(1): p. e18-e27.

McMahon, C.G., Efficacy of dapoxetine in the treatment of premature ejaculation. Clinical Medicine Insights: Reproductive Health, 2011. 5: p. CMRH. S7337.

Buvat, J., et al., Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. European urology, 2009. 55(4): p. 957-968.

Giuliano, F., 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends in neurosciences, 2007. 30(2): p. 79-84.

Choi, J.B., et al., Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: a multicenter, randomized, double-blind, phase III clinical trial. The Journal of Urology, 2019. 201(1): p. 147-153.

Kim, S.W., et al., Tolerability and adequate therapeutic dosage of oral clomipramine for the treatment of premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose, parallel-grouped clinical study. International journal of impotence research, 2018. 30(2): p. 65-70.

Waldinger, M.D., et al., Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. Journal of clinical psychopharmacology, 1998. 18(4): p. 274-281.

Waldinger, M.D., A.H. Zwinderman, and B. Olivier, SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. Journal of clinical psychopharmacology, 2001. 21(6): p. 556-560.

Tanrikut, C. and P.N. Schlegel, Antidepressant-associated changes in semen parameters. Urology, 2007. 69(1): p. 185. e5-185. e7.

Atikeler, M., I. Gecit, and F. Senol, Optimum usage of prilocaine‐lidocaine cream in premature ejaculation. Andrologia, 2002. 34(6): p. 356-359.

Busato, W. and C. Galindo, Topical anaesthetic use for treating premature ejaculation: a double‐blind, randomized, placebo‐controlled study. BJU international, 2004. 93(7): p. 1018-1021.

Sutton, M., et al., Promescent has a cytotoxic impact on fresh human sperm in vitro. Urology, 2018. 114: p. 95-98.

Henry, R., A. Morales, and M.G. Wyllie, TEMPE: topical eutectic-like mixture for premature ejaculation. Expert opinion on drug delivery, 2008. 5(2): p. 251-261.

Dinsmore, W.W., et al., Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol‐delivery form of lidocaine‐prilocaine for treating premature ejaculation. BJU international, 2007. 99(2): p. 369-375.

Frink, M.C., et al., Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittel-Forschung, 1996. 46(11): p. 1029-1036.

Bar-Or, D., et al., A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. European urology, 2012. 61(4): p. 736-743.

McMahon, C.G., et al., Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. The journal of sexual medicine, 2005. 2(3): p. 368-375.

McMAHON, C.G., et al., Efficacy of type‐5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review. BJU international, 2006. 98(2): p. 259-272.